Literature DB >> 31356273

Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Shugo Mizuno1, Hiroyuki Kato1, Hiroki Yamaue2, Tsutomu Fujii3, Sohei Satoi4, Akio Saiura5, Yoshiaki Murakami6, Masayuki Sho7, Masakazu Yamamoto8, Shuji Isaji1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate how often left-sided portal hypertension (LPH) develops and how LPH affects the long-term outcomes of patients with pancreatic cancer treated with pancreaticoduodenectomy (PD) and resection of the portal vein (PV)/superior mesenteric vein (SMV) confluence. SUMMARY BACKGROUND DATA: Little is known about LPH after PD with resection of the PV/SMV confluence.
METHODS: Overall, 536 patients who underwent PD with PV/SMV resection were enrolled. Among them, we mainly compared the SVp group [n=285; the splenic vein (SV) was preserved] and the SVr group (n = 227; the SV was divided and not reconstructed).
RESULTS: The incidence of variceal formation in the SVr group increased until 3 years after PD compared with that in the SVp group (38.7% vs 8.3%, P < 0.001). Variceal bleeding occurred in the SVr group (n = 9: 4.0%) but not in the SVp group (P < 0.001). In the multivariate analysis, the risk factors for variceal formation were liver disease, N factor, conventional PD, middle colic artery resection, and SV division. The only risk factor for variceal bleeding was SV division. The platelet count ratio at 6 months after PD was significantly lower in the SVr group than in the SVp group (0.97 vs 0.82, P < 0.001), and the spleen-volume ratios at 6 and 12 months were significantly higher in the SVr group than in the SVp group (1.38 vs 1.00 and 1.54 vs 1.09; P < 0.001 and P < 0.001, respectively).
CONCLUSIONS: PD with SV division causes variceal formation, bleeding, and thrombocytopenia.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 31356273     DOI: 10.1097/SLA.0000000000003487

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma.

Authors:  Kazuyuki Gyoten; Shugo Mizuno; Motonori Nagata; Takahiro Ito; Aoi Hayasaki; Yasuhiro Murata; Akihiro Tanemura; Naohisa Kuriyama; Masashi Kishiwada; Hiroyuki Sakurai
Journal:  Ann Gastroenterol Surg       Date:  2022-02-10

2.  A new option for laparoscopic spleen-preserving distal pancreatectomy: three cases with splenic artery preservation and resection of the splenic vein.

Authors:  Masataka Okuno; Yasuhiro Shimizu; Yoshiki Senda; Seiji Natsume; Shoji Kawakatsu; Seiji Ito; Koji Komori; Tetsuya Abe; Kazunari Misawa; Yuichi Ito; Takashi Kinoshita; Eiji Higaki; Hironori Fujieda; Yusuke Sato; Akira Ouchi; Masato Nagino; Kazuo Hara
Journal:  J Surg Case Rep       Date:  2022-04-03

3.  Computed tomography combined with gastroscopy for assessment of pancreatic segmental portal hypertension.

Authors:  Yu-Li Wang; Han-Wen Zhang; Fan Lin
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

4.  Should the Splenic Vein Be Preserved-Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer.

Authors:  Sung Hyun Kim; Seung-Seob Kim; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

Review 5.  Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review.

Authors:  Dajun Yu; Xiaolan Li; Jianping Gong; Jinzheng Li; Fei Xie; Jiejun Hu
Journal:  BMC Gastroenterol       Date:  2020-08-18       Impact factor: 3.067

6.  The clinical applicability of percutaneous splenic vein stent implantation for pancreatic portal hypertension.

Authors:  Jingjing Liu; Qingbing Wang; Xiaoyi Ding; Qin Liu; Wei Huang; Junwei Gu; Zhongmin Wang; Wei Wu; Zhiyuan Wu
Journal:  BMC Gastroenterol       Date:  2022-03-25       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.